Morocco signed a new regulatory agreement in March 2026 allowing cannabis based medical products to enter the country’s official pharmaceutical approval system for the first time.
Morocco has historically been one of the world’s largest producers of cannabis resin.
Morocco has taken another step toward building a regulated cannabis industry by establishing a framework that allows cannabis derived health products to be evaluated and registered like traditional medicines.
The agreement was signed in Rabat on March 14, 2026 between Morocco’s National Agency for the Regulation of Cannabis Activities and the country’s national medicines authority. The partnership creates a pathway for cannabis based therapeutics to be reviewed, approved, and distributed through Morocco’s pharmaceutical system.
Morocco approved a regulatory agreement allowing cannabis based medical products to enter the national pharmaceutical registration system.
For a country historically known as one of the world’s largest producers of hashish, the development represents a major shift toward a regulated medical cannabis economy.
Morocco Integrates Cannabis Into Its Pharmaceutical System
The new agreement connects Morocco’s cannabis regulator with the government agency responsible for approving medicines and health products.
Under the framework, cannabis based treatments must pass through the same regulatory process required for other pharmaceutical products. This includes safety evaluations, quality verification, and formal product registration before reaching patients.
Health authorities say the system is designed to ensure cannabis derived therapies meet strict medical standards while opening the door for regulated innovation in cannabinoid medicine.
By integrating cannabis into the pharmaceutical approval pipeline, Morocco is signaling that cannabis is no longer treated only as an agricultural crop but as a legitimate component of its healthcare sector.
A Key Step in Morocco’s Cannabis Reform
Morocco legalized cannabis cultivation for medical and industrial purposes in 2021.
The reform focused largely on the country’s northern Rif region, where cannabis farming has historically supported rural communities but existed largely outside formal regulation.
Since legalization, the Moroccan government has been gradually building a framework that licenses farmers, regulates production, and encourages the creation of legal cannabis supply chains.
The new pharmaceutical agreement adds a critical layer to that system by focusing specifically on cannabis based medical products.
Rather than limiting reform to raw cultivation or exports, Morocco is beginning to support the development of finished cannabis medicines that can move through official healthcare channels.
From Hash Production to Regulated Cannabis Industry
For decades Morocco has been widely associated with the global hash trade, particularly cannabis resin produced in the Rif Mountains.
The region has historically supplied large quantities of cannabis products that reached European illicit markets.
Government reforms are now attempting to transform that legacy into a regulated industry.
By licensing growers and establishing formal oversight, Morocco aims to shift cannabis production toward legitimate sectors such as medicine, pharmaceuticals, cosmetics, and industrial materials.
Officials also hope the legal framework will allow farmers to transition away from illicit markets and into licensed production networks.
Morocco Positions Itself in the Global Medical Cannabis Market
Morocco’s regulatory move reflects a broader global trend where countries with historic cannabis cultivation regions are moving to formalize the industry.
Medical cannabis programs now exist in more than 50 countries as governments explore how cannabinoids can be integrated into healthcare systems.
By creating a pharmaceutical pathway for cannabis based treatments, Morocco positions itself to participate in a growing global market for cannabis derived medical ingredients.
If the regulatory system develops successfully, Morocco could become a significant supplier of cannabis inputs for pharmaceutical and wellness industries.
The policy also has the potential to bring economic stability to farming communities in the Rif region while improving oversight of cannabis production nationwide.
Morocco’s agreement allowing cannabis medicines to enter the national pharmaceutical system marks another step in the country’s transition from a historic hash producing region into a regulated medical cannabis economy. The policy also positions Morocco to participate in the expanding global market for cannabis based therapeutics.
Black Cannabis Magazine is your go to platform for cannabis culture news and lifestyle content with a focus on diversity and inclusion. For more information visit www.blackcannabismagazine.com.
Copyright 2026 Black Cannabis Magazine. Distributed by Hazey Taughtme LLC.
